Genetic assays help you to determine the potential genetic toxicity of your novel drug, chemical or cosmetic. We conduct hundreds of assays to meet regulatory guidelines and GLP standards each year.
Customization is available.
| Toxicology Services & Tests | Hazard Identification (in vitro) | Hazard Evaluation & Risk Assessment (in vivo) |
|---|---|---|
| Ames test | * | |
| Gene mutation | * | |
| Micronucleus | ** | *** |
| Comet | * | **** |
| Combined micronucleus/Comet | ***/**** | |
| Non-disjunction testing using FISH or antikinetochore | * | |
| Cytotoxicity & phototoxicity | * | |
| Clinical trial & occupational cytogenetics monitoring | * | |
| EPISKIN™ | * | |
| EpiDerm™ | * | |
| Eye irritation (BCOP) | * | |
| Rodent bone marrow cytogenetics | * | |
| Transgenic rodent mutation assays (Muta™Mouse) | **** |
The world’s demand for safe products is growing, and the demand for innovation in genetic toxicology and in vitro models is growing along with it. This is why we have expanded our genetic toxicology facilities by 30 percent, including new in vitro alternatives. Explore all of your genetic toxicology study options.
Over the past five years, we’ve invested more than $700 million in nonclinical development to enhance our capabilities for your programs. From expanded lab space in our U.S., European and Asia Pacific sites to state-of-the-art instrumentation and digitized workflows, we’ve innovated where it matters most to empower your healthcare mission.
